Skip to Main Content

Author Details

Brigitte L Th??riault
Ontario Institute for Cancer Research, University Avenue
2004
21
14
PMIDPaper TitleJournal TitlePublished Year
36793435Discovery of OICR12694: A Novel, Potent, Selective, and Orally Bioavailable BCL6 BTB Inhibitor.ACS Med Chem Lett2023
37075613Targeting tumour-associated macrophages in hodgkin lymphoma using engineered extracellular matrix-mimicking cryogels.Biomaterials2023
34662547Chemical Genetics Screen Identifies COPB2 Tool Compounds That Alters ER Stress Response and Induces RTK Dysregulation in Lung Cancer Cells.J Mol Biol2021
32094923A drug discovery platform to identify compounds that inhibit EGFR triple mutants.Nat Chem Biol2020
26313483Corrigendum: Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients.Nat Protoc2015
24433356The genomic landscape of retinoblastoma: a review.Clin Exp Ophthalmol2014
25528264The role of KIF14 in patient-derived primary cultures of high-grade serous ovarian cancer cells.J Ovarian Res2014
24626475Transcriptional and epigenetic regulation of KIF14 overexpression in ovarian cancer.PLoS One2014
23498719Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies.Lancet Oncol2013
23913227Establishment of primary cultures from ovarian tumor tissue and ascites fluid.Methods Mol Biol2013
21618518Kinesin family member 14: an independent prognostic marker and potential therapeutic target for ovarian cancer.Int J Cancer2012
23209302KIF14 negatively regulates Rap1a-Radil signaling during breast cancer progression.J Cell Biol2012
22336108Regulation of p14ARF expression by miR-24: a potential mechanism compromising the p53 response during retinoblastoma development.BMC Cancer2012
22331504Author response: Does the time of inactivation of pRb determine the cell of origin of retinoblastoma?Invest Ophthalmol Vis Sci2012
21699706On the path to translation: Highlights from the 2010 Canadian Conference on Ovarian Cancer Research.J Ovarian Res2011
21862643The TAg-RB murine retinoblastoma cell of origin has immunohistochemical features of differentiated Muller glia with progenitor properties.Invest Ophthalmol Vis Sci2011
21945631Human ovarian cancer cell morphology, motility, and proliferation are differentially influenced by autocrine TGFβ superfamily signalling.Cancer Lett2011
18372118Autocrine BMP4 signalling regulates ID3 proto-oncogene expression in human ovarian cancer cells.Gene2008
17272306BMP4 induces EMT and Rho GTPase activation in human ovarian cancer cells.Carcinogenesis2007
17406520Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients.Nat Protoc2006
15633809The effect of Gu-Sui-Bu (Drynaria fortunei) on bone cell activity.Am J Chin Med2004
  • 1 - 21 of 21

Recommended Authors

The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 1
National Taiwan University College of Medicine
Career Start Year 2008
Number of shared co-authors 0
University of Minnesota
Career Start Year 2008
Number of shared co-authors 1
Peter MacCallum Cancer Centre
Career Start Year 2005
Number of shared co-authors 1
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 0
University of British Columbia
Career Start Year 2004
Number of shared co-authors 1
Peter MacCallum Cancer Centre
Career Start Year 2004
Number of shared co-authors 0
Peter MacCallum Cancer Centre
Career Start Year 2002
Number of shared co-authors 0
Aier Eye Hospital of Wuhan University
Career Start Year 2001
Number of shared co-authors 2
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 0
University of Virginia
Career Start Year 2000
Number of shared co-authors 0
The Westmead Institute for Medical Research, University of Sydney
Career Start Year 2000
Number of shared co-authors 0
Perlmutter Cancer Center
Career Start Year 1999
Number of shared co-authors 1
Imperial College London
Career Start Year 1999
Number of shared co-authors 0
Ovarian Cancer Action Research Centre, Imperial College London
Career Start Year 1996
Number of shared co-authors 1
CRUK Cambridge Institute, University of Cambridge
Career Start Year 1995
Number of shared co-authors 1
University of Chicago
Career Start Year 1993
Number of shared co-authors 0
Fox Chase Cancer Center
Career Start Year 1993
Number of shared co-authors 0
David Geffen School of Medicine, University of California at Los Angeles
Career Start Year 1992
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 0
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Career Start Year 1990
Number of shared co-authors 0
Oregon Health & Science University
Career Start Year 1989
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 0
Peter MacCallum Cancer Centre
Career Start Year 1983
Number of shared co-authors 2
Mayo Clinic Jacksonville
Career Start Year 1982
Number of shared co-authors 0
David Geffen School of Medicine, University of California los angeles
Career Start Year 1981
Number of shared co-authors 1
University of Pennsylvania School of Medicine
Career Start Year 1980
Number of shared co-authors 2
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 3
Westmead Hospital
Career Start Year 1972
Number of shared co-authors 1

Collaborators

The Eye Cancer Clinic, Princess Margaret Cancer Centre, Hospital for Sick Children
Co-authored papers 9
Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children
Co-authored papers 6
Indiana University School of Medicine
Co-authored papers 5
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 4
The Hospital for Sick Children
Co-authored papers 4
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 4
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 3
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 3
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 3
University of Toronto, Canada Mediterranean Institute for Life Sciences
Co-authored papers 2
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 2
University Health Network, University of Toronto
Co-authored papers 2
Ontario Cancer Institute/Princess Margaret Hospital, University Health Network
Co-authored papers 2
Princess Margaret Cancer Centre, University Avenue
Co-authored papers 2
Clinical Biochemistry Unit
Co-authored papers 1
Toronto Western Hospital
Co-authored papers 1
University of Alberta
Co-authored papers 1
Institute for Research in Immunology and Cancer, Universite de Montreal
Co-authored papers 1
Co-authored papers 1
Toronto Western Hospital
Co-authored papers 1
University of Pennsylvania
Co-authored papers 1
VU University Medical Center
Co-authored papers 1
University of California los angeles
Co-authored papers 1
Sunnybrook Research Institute
Co-authored papers 1
School of Pharmacy, University of Waterloo
Co-authored papers 1
Institute of Human Genetics, University Hospital Essen, University Duisburg-Essen
Co-authored papers 1
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Princess Margaret Cancer Centre
Co-authored papers 1
University of Toronto
Co-authored papers 1
University of Toronto
Co-authored papers 1